Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of ARS 368.19 trillion. The enterprise value is 400.73 trillion.

Market Cap	368.19T
Enterprise Value	400.73T

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Mar 12, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-3.84%
Shares Change (QoQ)	-1.02%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	37.72%
Float	1.83B

Valuation Ratios

The trailing PE ratio is 18.67 and the forward PE ratio is 15.35.

PE Ratio	18.67
Forward PE	15.35
PS Ratio	4.77
PB Ratio	6.00
P/TBV Ratio	n/a
P/FCF Ratio	13.72
P/OCF Ratio	12.75
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.14, with an EV/FCF ratio of 14.94.

EV / Earnings	20.32
EV / Sales	4.97
EV / EBITDA	11.14
EV / EBIT	13.72
EV / FCF	14.94

Financial Position

The company has a current ratio of 0.88, with a Debt / Equity ratio of 0.72.

Current Ratio	0.88
Quick Ratio	0.58
Debt / Equity	0.72
Debt / EBITDA	1.27
Debt / FCF	1.64
Interest Coverage	18.35

Financial Efficiency

Return on equity (ROE) is 32.62% and return on invested capital (ROIC) is 16.78%.

Return on Equity (ROE)	32.62%
Return on Assets (ROA)	12.13%
Return on Invested Capital (ROIC)	16.78%
Return on Capital Employed (ROCE)	27.17%
Revenue Per Employee	1.02B
Profits Per Employee	259.95M
Employee Count	75,883
Asset Turnover	0.53
Inventory Turnover	2.17

Taxes

In the past 12 months, Novartis AG has paid 2.79 trillion in taxes.

Income Tax	2.79T
Effective Tax Rate	12.40%

Stock Price Statistics

The stock price has increased by +74.98% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+74.98%
50-Day Moving Average	48,554.90
200-Day Moving Average	39,685.20
Relative Strength Index (RSI)	56.33
Average Volume (20 Days)	182

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of ARS 77.26 trillion and earned 19.73 trillion in profits. Earnings per share was 10,003.28.

Revenue	77.26T
Gross Profit	58.91T
Operating Income	28.03T
Pretax Income	22.50T
Net Income	19.73T
EBITDA	34.16T
EBIT	28.03T
Earnings Per Share (EPS)	10,003.28

Full Income Statement

Balance Sheet

The company has 13.25 trillion in cash and 43.89 trillion in debt, giving a net cash position of -30,636.16 billion.

Cash & Cash Equivalents	13.25T
Total Debt	43.89T
Net Cash	-30,636.16B
Net Cash Per Share	n/a
Equity (Book Value)	61.33T
Book Value Per Share	31,662.76
Working Capital	-5,210.64B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 28.88 trillion and capital expenditures -2,051.64 billion, giving a free cash flow of 26.83 trillion.

Operating Cash Flow	28.88T
Capital Expenditures	-2,051.64B
Free Cash Flow	26.83T
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 76.25%, with operating and profit margins of 36.29% and 25.53%.

Gross Margin	76.25%
Operating Margin	36.29%
Pretax Margin	29.13%
Profit Margin	25.53%
EBITDA Margin	44.21%
EBIT Margin	36.29%
FCF Margin	34.73%

Dividends & Yields

This stock pays an annual dividend of 624.65, which amounts to a dividend yield of 1.24%.

Dividend Per Share	624.65
Dividend Yield	1.24%
Dividend Growth (YoY)	34.57%
Years of Dividend Growth	2
Payout Ratio	54.32%
Buyback Yield	3.84%
Shareholder Yield	5.08%
Earnings Yield	5.36%
FCF Yield	7.29%

Dividend Details

Stock Splits

The last stock split was on October 22, 2020. It was a forward split with a ratio of 2.

Last Split Date	Oct 22, 2020
Split Type	Forward
Split Ratio	2

Scores

Novartis AG has an Altman Z-Score of 3.8 and a Piotroski F-Score of 7.

Altman Z-Score	3.8
Piotroski F-Score	7